Total Funding
38
12
Total FundingSeed raised
Growth Score 38 in past quarter
-1 pts
Heat Score 12 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
622624
EarlyCell is a biotechnology company that develops genetic and expression diagnostics for unmet or poorly diagnosed conditions.
- Ken Reed: Co-Founder and Board Member
- David Jackson: SVP, Director of Genetics, and Co-founder
About the Company
EarlyCell is a biotechnology company that develops genetic and expression diagnostics for unmet or poorly diagnosed conditions. The company's technology is focused on rare cells and modern molecular genetic and expression analysis (NGS, microarray, and FACS). It was founded in 2015 and is headquartered in Cleveland, Ohio, USA.